Key result
Ramipril and captopril acted as weak inhibitors of PGI2 synthesis in ACE(-) human arterial smooth muscle cells, suggesting a non-renin-angiotensin-mediated effect on eicosanoid synthesis.
Answers are grounded in this paper and cite their sources.
ACE inhibitors may exert non-renin-angiotensin-mediated pharmacological effects on eicosanoid synthesis in human arterial smooth muscle cells.
Angiotensin converting enzyme (ACE) inhibitors were evaluated from their effects on human arterial smooth muscle cells in culture. [3H]ramipril binding has been determined in two different cell lines exhibiting ACE(+) and ACE(-) phenotypes. Specific binding occurred only in ACE(+) cells, was saturable, and displayed a Kd of 1 nM with a beta max value of 3.5 fmol/10(6) cells. Ramipril specific binding did not significantly modulate PGI2 synthesis in ACE(+) cells. By contrast, ramipril and, to a lesser extent, captopril appeared as weak inhibitors of PGI2 synthesis in ACE(-) cells. These data indicate that human arterial SMCs may express several phenotypes of the renin-angiotensin system under culture conditions and that ACE inhibitors may exert a non-renin-angiotensin-mediated pharmacological effect on eicosanoid synthesis.
No takes yet. Share an insight, caveat, or question.
Larrue et al. (1989) studied Cultured human arterial smooth muscle cells. ACE inhibitors (ramipril, captopril) was evaluated on [3H]ramipril binding and PGI2 synthesis. Ramipril and captopril acted as weak inhibitors of PGI2 synthesis in ACE(-) human arterial smooth muscle cells, suggesting a non-renin-angiotensin-mediated effect on eicosanoid synthesis.
Synapse has enriched 10 related papers. Consider them for comparative context: